Monica Ligueros-Saylan’s Email & Phone

Image of Monica Ligueros-Saylan

Monica Ligueros-Saylan

Executive Director, Global Program Medical Director @ Novartis

Monica Ligueros-Saylan Contact Details

Location:
Greater New York City Area
Work:
Executive Director, Global Program Medical Director @ Novartis
Senior Global Clinical Leader, Oncology Clinical Development @ Novartis
Senior Medical Director, Program Section Leader Global Registrations @ Novartis
Education:
Post doctoral Fellow, Clinical Pharmacology @ Cornell University Medical College, New York, N.Y.
About:

Executive Director, Global Program Medical Director @ From May 2013 to Present (2 years 8 months) Senior Global Clinical Leader, Oncology Clinical Development @ From March 2010 to May 2013 (3 years 3 months) Senior Medical Director, Program Section Leader Global Registrations @ From August 2008 to March 2010 (1 year 8 months) Director, Translational Medicine, Cardiovascular, 

Looking for a different Monica Ligueros-Saylan?

Get an email address for anyone on LinkedIn with the ContactOut Chrome extension
Install the extension - it's free!

ContactOut is used by recruiters at 76% of the Fortune 500 companies

Similar Profiles to Monica Ligueros-Saylan

Recruiters looking for Monica Ligueros-Saylan also viewed
Most popular profiles
Related profiles
  • No profiles to display.

Looking for colleagues of Chris Shelby at Company Inc?

Image of Marisa Marisa Talbot
Novartis UK Compliance
Image of Iryna Iryna Lobach
Senior Principal Biostatistician
Image of Tracy Tracy Hourigan
Oncology medical affairs and clinical devlopment, Regional Scientific Director , West area
Image of Amy Amy Rudolph
VP, Head Early Development and Health Economics and Outcomes Research
Image of Daniel Daniel Lee
Associate Director, Brand Analytics, Strategic Insights and Analytics
Image of Christina Christina Lund-Jacobsen
Nordic Head of Training
Image of Lars Lars Thobo-Carlsen
Head Financial Planning and Analysis Ops
Image of Erik Erik Heegaard
Novartis
Image of Morten Morten Blegvad
Novartis